2NW3

Crystal structure of HLA-B*3508 presenting EBV peptide EPLPQGQLTAY at 1.7A

Summary for 2NW3

• Entry DOI: 10.2210/pdb2nw3/pdb
• Related: 2NW2
• Descriptor: HLA class I histocompatibility antigen, B-35 alpha chain, Beta-2-microglobulin, EBV peptide EPLPQGQLTAY, ... (4 entities in total)
• Functional Keywords: mhc, hla-b*3508, immune system
• Biological source: Homo sapiens (human); More
• Cellular location: Membrane; Single-pass type I membrane protein: P30685; Secreted: P61769
• Total number of polymer chains: 3
• Total formula weight: 44948.78

Authors

Tynan, F.E.,Reid, H.H.,Rossjohn, J. (deposition date: 2006-11-14, release date: 2007-02-27, Last modification date: 2023-10-25)

Primary citation

Tynan, F.E.,Reid, H.H.,Kjer-Nielsen, L.,Miles, J.J.,Wilce, M.C.,Kostenko, L.,Borg, N.A.,Williamson, N.A.,Beddoe, T.,Purcell, A.W.,Burrows, S.R.,McCluskey, J.,Rossjohn, J.
A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule
Nat.Immunol., 8:268-276, 2007

PubMed Abstract: Plasticity of the T cell receptor (TCR) is a hallmark of major histocompatibility complex (MHC)-restricted T cell recognition. However, it is unclear whether interactions of TCR and peptide-MHC class I (pMHCI) always conform to this paradigm. Here we describe the structure of a TCR, ELS4, in its non-ligand-bound form and in complex with a prominent 'bulged' Epstein-Barr virus peptide bound to HLA-B(*)3501. This complex was atypical of previously characterized TCR-pMHCI interactions in that a rigid face of the TCR crumpled the bulged antigenic determinant. This peptide 'bulldozing' created a more featureless pMHCI determinant, allowing the TCR to maximize MHC class I contacts essential for MHC class I restriction of TCR recognition. Our findings represent a mechanism of antigen recognition whereby the plasticity of the T cell response is dictated mainly by adjustments in the MHC-bound peptide.

PubMed: 17259989
DOI: 10.1038/ni1432

Experimental method

X-RAY DIFFRACTION (1.7 Å)